Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 381-400 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 381 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 2 | Thesis: There is insufficient reviewed evidence in these reviewed sources to support an opportunity thesis beyond a broad statement that the company is building space infrastructure. Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use. Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence. |
| 382 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence-level rationale suggests Star Catcher is a space startup building space-based power infrastructure, but the ranking reviewed sources provide no direct positive evidence retained inside the 90-day recent evidence window, so there is insufficient basis for a positive 1 year+ opportunity thesis from admissible evidence. Why now: Why now is weak because the company had 10 articles considered, but zero article IDs and zero evidence remained after the 90-day recent evidence window cutoff of March 29, 2026; recency-based business-state judgment is therefore unavailable from these reviewed sources. Caveats: No retained evidence after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 membership rationale is not directional proof and cites support article IDs without, so it cannot be used as a fully cited factual thesis. |
| 383 | Starfighters Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources rationale suggests Starfighters Space has air-launch and hypersonic testing relevance, but no within the recent evidence window direct evidence or citable are present in the reviewed sources output, so that does not support a scored positive thesis here. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Starfighters Space. Caveats: Phase-2 membership rationale references multiple article IDs, but the reviewed sources provide no article for citation. |
| 384 | Starfish Space lowweak | Opp 1 Risk 1 | Thesis: Membership rationale indicates autonomous proximity-operations progress, but no retained 90-day direct positive evidence is available in the served reviewed sources to support a durable upside thesis. Why now: No retained article IDs or evidence remain after recent evidence filtering, so there is no current evidence-based catalyst in the reviewed sources. Caveats: Single-article historical context is not retained within the recent evidence window. Absence of negative evidence is not positive evidence. Scoring is conservative because the current reviewed sources is effectively ungrounded for direction. |
| 385 | Starlab lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable because the reviewed sources retains no direct positive evidence within the recent evidence window. Why now: Why now is weak: the reviewed sources indicates zero evidence after recent evidence window, so there is no retained current catalyst or current operating-state evidence for Starlab. Caveats: Coverage after recent evidence window is empty for this company. Phase-2 membership rationale references, but no article summary or quoted evidence is included in the retained reviewed sources, so it cannot be used for factual claims here. |
| 386 | StatSat lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not retain sufficient company-specific positive evidence to support an opportunity thesis. Why now: The membership rationale references article and says AISSat-4 is operated by StatSat, but no retained evidence or are present after recent evidence window, leaving recency and business impact uncertain. Caveats: The only described support is a limited operational reference, not a clear catalyst. No direct dated evidence row is retained in the reviewed sources. |
| 387 | Swedish Space Corporation lowweak | Opp 1 Risk 1 | Thesis: No supported positive thesis from the retained recent evidence window evidence. The reviewed sources only notes an indirect mention of international partnerships involving Sweden in a Firefly earnings transcript summary, without clearly establishing Swedish Space Corporation's role or business impact (: no provided in reviewed sources). Why now: There is no current catalyst supported by retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency and business-state changes cannot be assessed from these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase2 rationale is weaker than direct company-specific event evidence and should not be treated as strong proof. |
| 388 | Swoop Technologies lowweak | Opp 1 Risk 1 | Thesis: The only reviewed sources support is review-status context that Swoop was placed among Golden Dome contract awardees for networking/simulation, which could indicate defense/space-adjacent participation, but there is no direct positive evidence row or in the reviewed sources to support a durable opportunity thesis (: not provided in reviewed sources). Why now: No inside-recent evidence window evidence are available, and the reviewed sources reports articles after recent evidence window = 0 and evidence after recent evidence window = 0, so there is no supported near-term or long-horizon timing catalyst beyond generic context. Caveats: Single-article company universe but no representative article content or provided. Contract-award framing comes only through membership rationale, not direct evidence. No materiality, scale, or timing detail is available. |
| 389 | TelePIX lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence membership rationale suggests TelePIX is a space AI solutions company partnering on a VLEO satellite mission with an optical payload, which could imply long-horizon product or mission traction, but the reviewed sources provide no retained article summaries or direct positive evidence within the 90-day recent evidence window to support a stronger opportunity case. Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window, so there is no current retained catalyst evidence in the last 90 days despite membership support referencing article Caveats: Support exists only in the membership rationale, which cites article: but no or article summary is provided in the reviewed sources, so it cannot be cited as a factual claim under the the evidence standard. Evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. |
| 390 | Telesat Corp lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct positive evidence is available in the reviewed sources, so there is not enough support for an opportunity thesis despite cohort relevance. Why now: Coverage data reports zero article IDs after recent evidence window and zero evidence after recent evidence window, preventing a recency-based ranking call. Caveats: Membership rationale references satellite communications and Lightspeed progress, but no article or retained evidence are supplied for ranking use. Public company status does not itself create a thesis without evidence. |
| 391 | Terran Orbital lowweak | Opp 1 Risk 2 | Thesis: The only reviewed sources support is a membership rationale stating Lockheed's modular satellite platform leverages Terran Orbital production, which suggests manufacturing relevance, but there is no in-window company evidence to support a stronger opportunity call. Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence. Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence. |
| 392 | TESAT lowweak | Opp 1 Risk 1 | Thesis: TESAT appears in the reviewed sources only as a partner in Kepler Communications' ESA optical communications contract. Because relations are context-only in these reviewed sources, that cannot be used as direct counterparty propagation evidence, leaving no direct positive thesis support for TESAT itself (: not provided in reviewed sources). Why now: No inside-recent evidence window direct evidence are available, so there is no supported timing argument. Caveats: Relation evidence is context-only and cannot be propagated as direct contract evidence. No or representative article summary is provided. No company-specific materiality data is available. |
| 393 | TESAT Spacecom lowweak | Opp 1 Risk 1 | Thesis: TESAT Spacecom is only referenced in prior HydRON contract context involving other companies, which is too indirect to support a positive thesis under the the evidence standard. Why now: There is no within the recent evidence window direct company evidence. Membership rationale references, but no is provided and the support level is only provisional single-article context. Caveats: Support is explicitly supporting article context, not direct company-specific event evidence. No retained evidence after recent evidence window. Relations/context-only mentions cannot be used as counterparty propagation evidence. |
| 394 | Thales lowweak | Opp 1 Risk 1 | Thesis: A weak opportunity case exists only from the phase2 rationale, which says Thales Alenia Space was linked as prime contractor for Sentinel-1 Next Generation satellites, suggesting satellite manufacturing/radar exposure. However, the reviewed sources provide no available article summaries or evidence inside recent evidence window for Thales itself, and the rationale itself questions whether subsidiary evidence should propagate to the parent. Why now: There is no citable in-recent evidence window article summary or evidence row for Thales in these reviewed sources, and coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window. Caveats: Phase2 rationale references article ids: and: but no or summaries for them are included here. Parent/subsidiary propagation is explicitly uncertain in the reviewed sources rationale. No direct evidence were available after recent evidence window. |
| 395 | Trishul Space lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Trishul Space was placed in T-Hub's ORBIT spacetech accelerator context, which is not enough by itself to establish a durable positive 1 year+ thesis without direct company-specific progress evidence. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Trishul Space. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Accelerator participation context is weaker than direct commercial, funding, or technical milestone evidence. |
| 396 | True Anomaly Centennial lowweak | Opp 1 Risk 1 | Thesis: Potential long-horizon opportunity cannot be established from available evidence. The reviewed sources membership rationale says the company was selected in the U.S. Space Force Andromeda contract for space surveillance, but no direct within the recent evidence window evidence or article details are available for scoring. Why now: Why-now visibility is weak because the reviewed sources show zero evidence kept after recent evidence window for this company, so any claimed contract relevance lacks scoreable supporting detail in the current batch. Caveats: Reviewed evidence cites: in membership rationale but does not provide article summary or available evidence, so it cannot be used as direct scoring evidence. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Absence of negative evidence is not positive evidence. |
| 397 | ULA lowweak | Opp 1 Risk 1 | Thesis: ULA is identified as a launch provider in membership context, but the reviewed sources retains no 90-day positive evidence to support an investable long-horizon opportunity view. Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources. Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone. |
| 398 | Uncovr lowweak | Opp 1 Risk 1 | Thesis: A funding-roundup mention suggests some financing activity, but the reviewed sources have no usable direct positive evidence after recent evidence window and does not connect the company to a space-specific thesis. Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use. Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence. |
| 399 | United Launch Alliance lowweak | Opp 1 Risk 1 | Thesis: Insufficient admissible reviewed sources evidence to support a positive thesis within the 90-day recent evidence window, despite membership rationale identifying ULA as a rocket company tied to Vulcan and Atlas V contexts. Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials. Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included. |
| 400 | Univity lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources indicates Univity is a satellite startup that raised capital and plans a large VLEO constellation, but no dated within the recent evidence window evidence or article summaries are available here to support a stronger positive thesis. Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources. Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof. |
Risk view
Showing rows 221-240 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 221 | Spacety lowweak | Opp 2 Risk 2 | Thesis: There is no usable in-window article or evidence detail in the reviewed sources to validate the company’s current operating status, financing trajectory, or any adverse development, so the main risk is evidence absence rather than proven business trouble. Why now: There is no dated evidence retained after recent evidence window for Spacety in these reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency is uncertain. Caveats: No representative articles or evidence are provided after recent evidence window. The only support is the phase2 membership rationale, which is weaker than direct event/fact evidence and does not provide /article summaries here. Because there is no in-window evidence, scores remain low on both axes. |
| 222 | Spacium lowweak | Opp 1 Risk 2 | Thesis: No direct negative evidence is present; the main issue is stale evidence and resulting uncertainty about current momentum or business state. Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026. Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof. |
| 223 | SpinLaunch lowweak | Opp 2 Risk 2 | Thesis: Novel launcher and constellation buildout imply execution risk, but these reviewed sources provide no direct negative evidence within the recent evidence window. Why now: Why-now is weak because the reviewed sources show 0 evidence kept after the 90-day recent evidence window, so recency cannot be established from local evidence. Caveats: Phase2 membership rationale references and, but no article summaries or direct evidence are included, so they cannot be cited as factual support beyond noting the reviewed sources rationale. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score kept low because positive thesis is not directly grounded in usable article evidence in these reviewed sources. |
| 224 | SSC Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence risk is mainly lack of evidence visibility rather than documented negative developments. Without available direct evidence, current contract status, capex burden, and follow-on demand are unclear. Why now: Why now is weak because no evidence survived into the ranking reviewed sources despite the membership rationale. Caveats: Phase-2 membership rationale references: but no or direct evidence row is available here. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Do not infer opportunity from mission association alone without available evidence. |
| 225 | Star Catcher Industries, Inc. lowweak | Opp 1 Risk 2 | Thesis: Risk is mostly uncertainty risk because no kept recent evidence window evidence establish financing, contracts, milestones, or adverse developments. Why now: Why now is weak because the reviewed sources' membership rationale references article describing an orbital power grid concept, but no article or reviewed evidence are provided for ranking use. Caveats: No article is available for article. Coverage debug shows zero evidence after recent evidence window. Cannot elevate concept relevance into thesis attractiveness without direct business evidence. |
| 226 | Starcloud lowweak | Opp 4 Risk 2 | Thesis: The same rationale suggests category ambiguity and execution risk: orbital AI/data-center activity may be conceptually ambitious, but the reviewed sources does not prove commercialization, deployment, or durable demand. No direct adverse evidence is available, so risk remains moderate and evidence-light rather than event-driven. Why now: If the fundraising and product positioning are recent, they could support a multi-quarter buildout story, but the reviewed sources explicitly shows zero available evidence after recent evidence window, so recency and sequencing cannot be confirmed. Caveats: Most supportive facts appear only in membership rationale, not available evidence. Reported funding cannot be treated as fully validated without direct article support in reviewed sources. No, quote, or dated direct summary is available. |
| 227 | Stelleo lowweak | Opp 4 Risk 2 | Thesis: Risk remains modest because the reviewed sources offers no adverse evidence, but also no proof of contracts, funding, customer traction, or scaling milestones. That makes the opportunity early-stage and low-conviction. Why now: The article is within the recent evidence window and dated May 25, 2026, but it is a company-site style description rather than an independently reported business event, so it supports relevance more than momentum Evidence
Caveats: Evidence is article-level company context, not a direct commercial milestone. No direct traction, financing, or contract evidence is provided. Same-article repeated rows are not independent confirmation. |
| 228 | SWISSto12 lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources contain no retained article/evidence detail after recent evidence window to confirm deliveries, customer adoption, financing, or execution setbacks, so business risk cannot be judged confidently. Why now: There is no dated evidence retained after recent evidence window for SWISSto12. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so the timing case is not established from these reviewed sources. Caveats: Assessment relies only on the reviewed sources' membership rationale, not direct quoted event/fact evidence with support. No representative articles are included despite article IDs being referenced in the rationale. Potential opportunity could be meaningful, but evidentiary support inside these reviewed sources is too thin for a stronger score. |
| 229 | Terran Orbital lowweak | Opp 1 Risk 2 | Thesis: Risk scores slightly above minimal only because evidence absence is meaningful for ranking confidence and because the reviewed sources gives no current direct positive operating or contract evidence inside the recent evidence window. There is still no direct adverse event in the reviewed sources. Why now: There is no valid near-term or long-horizon catalyst from the reviewed sources because coverage data shows zero evidence after recent evidence window; current state cannot be confirmed from local evidence. Caveats: No evidence remained after the 90-day recent evidence window. The reviewed sources includes only sparse membership rationale, not current direct evidence. |
| 230 | The Exploration Company lowweak | Opp 5 Risk 2 | Thesis: Main risk is evidence thinness and uncertain recency: the reviewed sources contain no direct negative evidence, but the only business evidence is undated supporting article context, so current contract status and execution progress are uncertain. Why now: Why now is weak: the only cited catalyst is an undated article stating the company won an ESA cargo contract, and the reviewed sources provide no newer dated confirmation within the 90-day window. Recency-sensitive conclusions should therefore be cautious. Evidence
Caveats: Only undated article-context evidence is present; no direct structured positive event/facts survived. The reviewed sources includes no within the recent evidence window dated follow-up on financing, program execution, or milestone delivery. Article-level context is weaker than direct company event/fact evidence. |
| 231 | True Anomaly Centennial lowweak | Opp 3 Risk 2 | Thesis: Risk remains moderate because the reviewed sources provide no direct available evidence after recent evidence window to confirm award economics, schedule, or follow-on conversion. Why now: Government program selection could matter over 1 year+, but the reviewed sources does not provide surviving evidence with timing details after recent evidence window. Caveats: No -bearing direct evidence row is available for the referenced Andromeda selection article. Selection does not prove revenue realization or contract scale. |
| 232 | Umbra mediummedium | Opp 5 Risk 2 | Thesis: The main risk in these reviewed sources is evidentiary rather than business-specific: there is no direct negative evidence, but also no direct structured positive event row such as a contract, financing, or milestone within the recent evidence window. Opportunity therefore rests on supporting article context rather than stronger company-specific event evidence. Why now: The most recent dated context is June 22, 2026, which is within the 90-day recent evidence window and indicates Umbra currently operates a SAR constellation and serves government and commercial customers. However, no nearer-term catalyst row is available, so the timing case is moderate rather than strong. Evidence
Caveats: Evidence is supporting article context/weak context only, not a direct structured positive event row. The July 31, 2024 Umbra article is outside the 90-day dated recent evidence window and was dropped for recency-sensitive scoring. |
| 233 | United Launch Alliance lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available, so there is no supported negative thesis from these reviewed sources alone. Why now: The membership rationale cites articles: and: but no article summaries or evidence are available after recent evidence filtering for ranking. Caveats: Launch-industry membership is not itself a directional thesis. Coverage debug shows zero evidence after recent evidence window despite many considered articles. No direct contract, launch cadence, backlog, or failure evidence is available in these reviewed sources. |
| 234 | Viasat, Inc. mediummedium | Opp 4 Risk 2 | Thesis: Risk remains moderate because the reviewed sources provide only weak supporting article context rather than direct structured company events, limiting confidence in scope, economics, and timing of impact. Why now: Recent context exists within the recent evidence window: is dated June 11, 2026 and states Viasat was among operators selected under a combined $437.7 million award and has a defined supplier stack for its PTS-G satellite, which could matter over a 1 year+ horizon. Source date basis is source date. Evidence
Caveats: This is supporting article context only; the reviewed sources classifies it under weak context, so it is weaker than direct event/fact evidence. Same article appears in two weak-context rows and should not be treated as independent confirmation. An older Viasat company-hosted article exists but is outside recent evidence window, February 29, 2024 |
| 235 | Voyager Technologies Inc. lowweak | Opp 2 Risk 2 | Thesis: A mild risk prior exists only from uncertainty: despite many articles considered, no retained evidence remains after recent evidence window, so no current adverse thesis is established and business-state recency is unclear. Why now: There is no citable within the recent evidence window evidence in the reviewed sources to justify a strong 1 year+ 'why now' despite broad historical article coverage. Caveats: Phase-2 rationale references: and: but no or summaries are provided here. Coverage debug shows 78 articles considered but 0 article IDs after recent evidence window and 0 available evidence. Ticker ambiguity exists in aliases (VOYG, VYGR), but the required output ticker is VOYG. |
| 236 | VSBLTY Groupe Technologies Corp. lowweak | Opp 2 Risk 2 | Thesis: The same rationale implies adjacency rather than a clearly established core space operator role, creating execution and relevance risk, but no material adverse event evidence is available after recent evidence filtering. Why now: No reviewed sources-grounded timing support is available for why this matters now over a 1 year+ horizon; the reviewed sources retains zero evidence after the cutoff and provides no citable for article. Caveats: Reviewed evidence is limited to a membership rationale; there are no representative article summaries, or evidence after recent evidence window. The cited article id is not accompanied by a in the reviewed sources, so it cannot be used for factual claim citation. Slightly higher opportunity/risk than some peers reflects adjacency language in the reviewed sources rationale only, not strong direct evidence. |
| 237 | Xdlinx lowweak | Opp 2 Risk 2 | Thesis: No direct negative evidence is present; the practical risk to ranking is simply insufficient current evidence. Why now: The reviewed sources includes no representative article or retained evidence within the 90-day recent evidence window, so recency and current status are uncertain for Xdlinx in this screen. Caveats: No retained evidence after recent evidence window. Phase-2 membership support alone is not enough for a stronger score. |
| 238 | XDLINX Space Labs lowweak | Opp 2 Risk 2 | Thesis: Risk is modestly elevated versus some peers because the company appears only once in the reviewed sources, and the lack of retained recent evidence means the claimed business standing cannot be validated or updated within the recent evidence window. Why now: No current catalyst is evidenced; coverage after recent evidence window is empty. Caveats: Reviewed evidence mentions: but provides no. Higher-revenue claim is only from membership rationale and may not be current. No retained structured positive or negative evidence after recent evidence window. |
| 239 | Xona Space lowweak | Opp 3 Risk 2 | Thesis: Risk is mainly execution and proof-of-delivery risk because the surviving evidence is undated company context without dated commercial milestones, customers, or financing in the reviewed sources. Why now: Why now is weak: the only surviving evidence is undated, so recency-sensitive claims are uncertain Evidence
Caveats: Evidence is undated and should not be treated as recency proof. No direct positive event or traction evidence is available. Opportunity case is strategic but low-conviction. |
| 240 | ADAspace lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Risk remains low-scored due to lack of evidence rather than demonstrated safety. Why now: There is no usable within the recent evidence window evidence in the reviewed sources; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for ADAspace. Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. No direct positive or negative evidence survived the 90-day recent evidence window. |